Department of General Pathology, II Università di Napoli, Napoli, Italy.
Mol Cell Endocrinol. 2010 Oct 7;327(1-2):19-24. doi: 10.1016/j.mce.2010.06.014.
Steroid receptors act as ligand-dependent transcriptional factors. It has been observed that in addition to responding to cognate hormones with transcription activation, once hormone bound they are also capable of rapid responses following association with signaling effectors in the extra nuclear compartment. This novel aspect of steroid hormone action could influence our view of the cross talk between growth factor and steroid receptors. Increasing evidence shows that in hormone-responsive cells, a cross talk occurs between growth factors (EGF, IGF-1) and steroid hormone receptors that reciprocally regulate their action. To date, this has mostly been explained by modulation of steroid receptor transcriptional activity through growth factor receptor signaling activation. However, it is now known that growth factors might also act on extra nuclear steroid receptors, activating them via a hormone-independent mechanism. On the other hand, extra nuclear steroid receptors can regulate growth factor receptor activity either directly interfering with their transduction pathways, or inducing autocrine growth factor secretion. Here we discuss findings indicating that EGF, like steroid hormones, induces association of steroid receptors with Src thereby activating pathways that can trigger cell proliferation and migration. Since mammary and prostate cancers respond to both steroid hormones and growth factors, this association might be a putative target for human cancer therapy. Findings from our laboratory supporting this view are discussed.
甾体激素受体作为配体依赖性转录因子发挥作用。人们已经观察到,甾体激素受体除了对同源激素发生转录激活反应外,与核外信号效应器结合后,也能够迅速响应。甾体激素作用的这一新特性可能会影响我们对生长因子与甾体激素受体之间串扰的看法。越来越多的证据表明,在激素反应性细胞中,生长因子(EGF、IGF-1)与甾体激素受体之间发生串扰,它们相互调节彼此的作用。迄今为止,这主要通过生长因子受体信号激活来调节甾体激素受体的转录活性来解释。然而,现在已知生长因子也可以作用于核外甾体激素受体,通过非激素依赖的机制激活它们。另一方面,核外甾体激素受体可以通过直接干扰其转导途径或诱导自分泌生长因子分泌来调节生长因子受体的活性。在这里,我们讨论了一些研究结果,这些结果表明 EGF 与甾体激素一样,诱导甾体激素受体与 Src 结合,从而激活能够触发细胞增殖和迁移的信号通路。由于乳腺癌和前列腺癌对甾体激素和生长因子都有反应,这种结合可能是人类癌症治疗的一个潜在靶点。我们实验室的研究结果支持这一观点,对此进行了讨论。